Vaccine immune response | Possible treatments for Type 2 diabetes | MedTech
"He who cures a disease may be [the most skillful], but he that prevents it is the safest physician." — Thomas Fuller, English churchman and historian.
Today’s issue:
July 14, 2021
PANDEMIC INNOVATION
Image by torstensimon for Pixabay A look at vaccine immune response ST. LOUIS, MO—Researchers at Washington University School of Medicine in St. Louis have found evidence that the immune response to COVID-19 vaccines is both strong and long-lasting. The research involved extracting cells from people who received the Pfizer vaccine at three-, four-, five- and seven-week intervals. COVID-19 antibodies study DETROIT, MI—Beaumont Health, Southeast Michigan’s largest health care system, has launched a two-year study designed to better understand how a person develops vaccine-induced COVID-19 antibodies and how long those antibodies last. Post-infection treatment for COVID MANHATTAN, KANSAS—Kansas State University researchers have published a study that demonstrates successful post-infection treatment for SARS-CoV-2. College of Veterinary Medicine researchers found that animal models infected with SARS-CoV-2 and treated with an inhibitor of protease enzymes had significantly increased survival rates and decreased lung viral quantities. COVID-19 and the immunocompromised PITTSBURGH, PA—Researchers from the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center in Pennsylvania say that immunocompromised patients are at an increased risk for severe and protracted illness following infection with SARS-CoV-2. The analysis involved 107 health care personnel and 489 immunocompromised patients who had been fully immunized with the Moderna, Pfizer-BioNTech or the Johnson & Johnson vaccine. Share these stories!
PUDDLE HOPS: HEALTH TECH
Fast Future has followed medical and tech news around COVID-19 from the beginning of the pandemic. We’re adding coverage to this report related to health care innovation to feature more advances across Fast Future Country.
Share these stories!
REACH OUT Share stories, offer suggestions or leave a comment!
|